BioSpace News Archive

July 27, 2018 14:10 UTC --( BUSINESS WIRE )-- Qosina is a leading global supplier of more than 5,000 OEM single-use components to the medical and pharmaceutical industries. We offer free samples, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 certified, and operates in a 95,000 square-foot, climate-

CVS Health Corporation will be holding a conference call on Wednesday, August 8, 2018, at 8:30 a.m. (ET) with analysts and investors to discuss its second quarter financial results.

Abbott Laboratories(NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the FreeStyle® Libre 14 day Flash Glucose Monitoring system, which allows people with diabetes to wear the sensor up to 14 days with high accuracy.

Clinical development of Onxeo’s lead product candidate AsiDNA™ progressing to plan

MabVax Therapeutics Holdings, Inc., a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today filed a Verified Petition for Relief Under 8 Del.

Siamab Therapeutics, Inc. today announced the publication of positive preclinical data for its ST1 antibody drug conjugate (ADC) in multiple models of ovarian cancer.

MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that senior management will participate in a fireside chat at the RBC Capital Markets’ 2018 Healthcare Conference on Wednesday, February 21, 2018, at 8:30 a.m. ET in New York, NY.

Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced the closing of its initial public offering of 4,500,000 shares of common stock at a public offering price of $15.00 per share.

On Thursday, July 26, 2018, the NASDAQ Composite closed the trading session at 7,852.18, down 1.01%; the Dow Jones Industrial Average edged 0.44% higher, to finish at 25,527.07; and the S&P 500 closed at 2,837.44, slightly dropping 0.30%.

Welltower Inc. announced results for the quarter ended June 30, 2018. For the quarter, we generated net income attributable to common stockholders of $0.41 per share, FFO attributable to common stockholders of $1.02 per share and normalized FFO attributable to common stockholders of $1.00 per share.